Boothbay Fund Management LLC Makes New $786,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Boothbay Fund Management LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,619 shares of the company's stock, valued at approximately $786,000.

Several other hedge funds also recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare in the fourth quarter worth $36,000. Activest Wealth Management lifted its holdings in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares during the period. Pinnacle Bancorp Inc. raised its position in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after acquiring an additional 50 shares during the last quarter. Finally, Legacy Investment Solutions LLC boosted its stake in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HCA shares. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Robert W. Baird reiterated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Bank of America decreased their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Guggenheim began coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $381.13.

HCA Healthcare Stock Performance

HCA traded up $5.07 during midday trading on Friday, reaching $348.11. The company had a trading volume of 802,331 shares, compared to its average volume of 1,400,124. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market cap of $85.71 billion, a PE ratio of 15.84, a P/E/G ratio of 1.10 and a beta of 1.48. The business has a 50-day moving average price of $331.79 and a two-hundred day moving average price of $330.21. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.36 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.